CureVac starts Phase 3 clinical trial of its Covid-19 vaccine candidate By: MarketWatch December 14, 2020 at 07:56 AM EST Tübingen-based CureVac said the Phase 3 trial will include more than 35,000 volunteers in Europe and Latin America Read More >> Related Stocks: Astrazeneca Plc ADR Biontech Se ADR Curevac N.V. Gsk Plc ADR Microsoft Moderna Inc Pfizer
